#1 Clinical Trials Search in Europe

Clopidogrel

Clopidogrel, also known by the brand name Plavix, is an antiplatelet medication used in various clinical trials to investigate its effectiveness in treating different medical conditions. These trials aim to evaluate how clopidogrel works in preventing blood clots, reducing the risk of heart attacks and strokes, and its potential benefits in other health issues. The studies explore different aspects of clopidogrel use, including its efficacy, safety, and comparison with other treatments.

Table of Contents

What is Clopidogrel?

Clopidogrel is an important medication used to prevent blood clots in patients with various heart and blood vessel conditions. It’s known by several brand names, including Plavix and Iscover[1]. In some countries, it may also be available under names like Pregrel[2] or Pidogul[3]. Clopidogrel belongs to a class of drugs called antiplatelet agents, which help prevent platelets (a type of blood cell) from sticking together and forming clots[4].

How Clopidogrel Works

Clopidogrel works by blocking a specific receptor on platelets called P2Y12. By doing this, it prevents platelets from clumping together, which is a crucial step in blood clot formation. This action helps keep blood flowing smoothly through your arteries and veins[5]. The medication is particularly effective in preventing clots in patients who have had heart attacks, strokes, or certain heart procedures.

Conditions Treated with Clopidogrel

Clopidogrel is used to treat and prevent several cardiovascular conditions, including:

  • Acute Coronary Syndrome (ACS): This includes conditions like unstable angina and heart attacks. Clopidogrel helps reduce the risk of future heart problems in these patients[4].
  • Coronary Artery Disease (CAD): Patients with narrowed heart arteries may be prescribed clopidogrel to prevent complications[3].
  • After Stent Placement: Patients who have had a stent (a small tube) placed in their heart arteries often take clopidogrel to prevent blood clots from forming on the stent[6].
  • Peripheral Artery Disease (PAD): This condition affects blood vessels outside the heart and brain. Clopidogrel can help prevent complications in these patients.
  • Stroke Prevention: In some cases, clopidogrel may be used to prevent strokes in patients at high risk[1].

Dosage and Administration

The dosage of clopidogrel can vary depending on the condition being treated and individual patient factors. Common dosages include:

  • Loading Dose: In some situations, like before a heart procedure, patients may receive a higher initial dose (called a loading dose) of 300 mg or 600 mg[4].
  • Maintenance Dose: The usual daily dose is 75 mg, taken once a day[7].
  • Duration: The length of treatment can vary from a few months to indefinitely, depending on the patient’s condition and risk factors[6].

It’s crucial to take clopidogrel exactly as prescribed by your doctor and not to stop taking it without medical advice, as this could increase your risk of blood clots.

Clopidogrel in Clinical Trials

Numerous clinical trials have been conducted to study the effectiveness and safety of clopidogrel in various situations. Some key findings include:

  • Clopidogrel has been shown to be effective in reducing the risk of heart attacks, strokes, and other cardiovascular events in patients with acute coronary syndrome[4].
  • Studies have compared different dosing regimens of clopidogrel to find the most effective and safe approach for various patient groups[5].
  • Research has explored the use of clopidogrel in combination with other medications, such as aspirin, for enhanced effectiveness[3].
  • Some trials have investigated the long-term use of clopidogrel after stent placement to determine the optimal duration of therapy[6].

Side Effects and Safety Considerations

While clopidogrel is generally well-tolerated, it can cause side effects in some patients. Common side effects may include:

  • Increased risk of bleeding, including minor bruising or nosebleeds
  • Stomach upset or diarrhea
  • Headache
  • Dizziness

More serious, but rare, side effects can include severe bleeding or allergic reactions. It’s important to inform your doctor of any unusual symptoms or bleeding while taking clopidogrel[6].

Clopidogrel and Surgery

If you’re taking clopidogrel and need to undergo surgery, it’s crucial to inform your healthcare providers. In some cases, clopidogrel may need to be stopped before surgery to reduce the risk of excessive bleeding. The timing of when to stop clopidogrel before surgery can vary:

  • Some studies suggest stopping clopidogrel 5 days before surgery
  • Others indicate that stopping 3 days before surgery may be sufficient
  • In some cases, surgery may proceed without stopping clopidogrel, depending on the urgency and type of procedure[8]

Always follow your doctor’s specific instructions regarding clopidogrel use before any surgical procedure.

Aspect Details
Primary Uses in Trials Prevention of blood clots, reducing cardiovascular events, treatment of coronary artery disease
Conditions Studied COPD, myocardial infarction, stroke, coronary artery disease
Forms Studied Original brand (Plavix), generic versions, different salt formulations
Common Outcomes Measured Cardiovascular event rates, blood flow improvement, platelet function, bleeding risks
Safety Considerations Bleeding complications, bruising, stomach upset, rare blood disorders
Comparison Studies Generic vs. original formulations, different dosing regimens, combination with other drugs
Special Populations Patients undergoing PCI, post-stent placement, severe COPD patients

FAQ

  • What is clopidogrel used for in clinical trials? Clopidogrel is being studied for various conditions, including coronary artery disease, myocardial infarction (heart attack), stroke prevention, and even in patients with severe COPD (Chronic Obstructive Pulmonary Disease). It's primarily used to prevent blood clots and reduce the risk of cardiovascular events.
  • How does clopidogrel work? Clopidogrel works by inhibiting platelet aggregation. It blocks a specific receptor on platelets called P2Y12, which prevents platelets from sticking together and forming clots. This action helps to keep blood flowing smoothly through the arteries.
  • Are there different forms of clopidogrel used in trials? Yes, clinical trials have used different forms of clopidogrel, including the original brand Plavix and generic versions. Some studies compare these different formulations to assess their effectiveness and safety. There are also trials looking at different salts of clopidogrel, such as clopidogrel bisulfate and clopidogrel napadisilate.
  • What are some common outcomes measured in clopidogrel trials? Common outcomes measured include the rate of major cardiovascular events (like heart attacks and strokes), blood flow improvement in arteries, platelet function tests, bleeding risks, and overall patient survival. Some trials also look at the quality of life for patients taking clopidogrel.
  • Are there any risks associated with taking clopidogrel in clinical trials? Like all medications, clopidogrel can have side effects. In clinical trials, researchers monitor for bleeding complications, which can range from minor to severe. Other potential side effects may include bruising easily, stomach upset, and rarely, more serious conditions like blood disorders. The trials are designed to carefully assess these risks alongside the potential benefits.

Ongoing Clinical Trials on Clopidogrel

  • A study of drug combination (clopidogrel, acetylsalicylic acid, atorvastatin, rosuvastatin) for patients with covert brain infarction

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study of cangrelor and acetylsalicylic acid in patients with ischemic stroke requiring emergency carotid artery stenting and mechanical thrombectomy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy Luxembourg Spain

  • Study on Clopidogrel and Dalteparin Sodium for Preventing Blood Clots in Pancreatic Cancer Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study of clopidogrel and acetylsalicylic acid (aspirin) for prevention of cardiovascular events in patients who survived intracerebral hemorrhage stroke

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium The Netherlands

  • Study on the Safety and Effectiveness of Short Dual Antiplatelet Therapy with Ticagrelor, Clopidogrel, and Prasugrel in Patients Aged 65+ with Coronary Artery Disease

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Preventing Blood Clots in Patients with New-Onset Post-Operative Atrial Fibrillation after CABG Using Apixaban and Drug Combination

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Poland +1

Glossary

  • COPD: Chronic Obstructive Pulmonary Disease, a group of lung diseases that cause airflow blockage and breathing-related problems.
  • Myocardial Infarction: Commonly known as a heart attack, it occurs when blood flow to the heart is blocked, causing damage to the heart muscle.
  • Platelet Aggregation: The clumping together of platelets in the blood, which is a crucial step in blood clot formation.
  • Antiplatelet Medication: A type of drug that prevents platelets in the blood from sticking together, thus reducing the risk of blood clots.
  • Percutaneous Coronary Intervention (PCI): A non-surgical procedure used to treat narrowed coronary arteries of the heart, often involving the placement of a stent.
  • Stent: A tiny tube inserted into a narrowed artery to keep it open and allow better blood flow.
  • TIMI Flow: A scoring system used to assess blood flow in coronary arteries, often used in heart attack treatment studies.
  • Major Adverse Cardiovascular Events (MACE): A composite endpoint in clinical trials that typically includes death, myocardial infarction, and stroke.
  • Pharmacodynamics: The study of how a drug affects the body, including its mechanism of action and the relationship between drug concentration and effect.
  • Pharmacokinetics: The study of how the body processes a drug, including its absorption, distribution, metabolism, and excretion.

References

  1. https://clinicaltrials.gov/study/NCT00372216
  2. https://clinicaltrials.gov/study/NCT01349777
  3. https://clinicaltrials.gov/study/NCT01584791
  4. https://clinicaltrials.gov/study/NCT01505790
  5. https://clinicaltrials.gov/study/NCT01123824
  6. https://clinicaltrials.gov/study/NCT02327741
  7. https://clinicaltrials.gov/study/NCT04171687
  8. https://clinicaltrials.gov/study/NCT00724880